跳转至内容
Merck
CN

主要文件

查看所有文档

A39009

1-氨基蒽醌

≥96.5% purity, powder, crystals or chunks

别名:

冰染重氮组分 36, 坚牢红 AL

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C14H9NO2
化学文摘社编号:
82-45-1
分子量:
223.23
NACRES:
NA.47
PubChem Substance ID:
24890825
UNSPSC Code:
12171500
Colour Index Number:
37275
EC Number:
201-423-5
MDL number:
MFCD00001213
Beilstein/REAXYS Number:
396360
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

1-氨基蒽醌, ≥96.5% (HPLC)

Quality Level

100

assay

≥96.5% (HPLC)

form

powder, crystals or chunks

color

dark brown

mp

253-255 °C (lit.)

application(s)

diagnostic assay manufacturing
hematology
histology

storage temp.

room temp

SMILES string

Nc1cccc2C(=O)c3ccccc3C(=O)c12

InChI

1S/C14H9NO2/c15-11-7-3-6-10-12(11)14(17)9-5-2-1-4-8(9)13(10)16/h1-7H,15H2

InChI key

KHUFHLFHOQVFGB-UHFFFAOYSA-N

Biochem/physiol Actions

1-氨基蒽醌具有增加蒽醌衍生物在超临界二氧化碳中溶解度的能力。

Still not finding the right product?

Explore all of our products under 1-氨基蒽醌

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
SHBS7854
0000185550
0000185550
SHBP4587
MKCJ8412

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Aneta Hałka-Grysińska et al.
Journal of chromatography. A, 1610, 460516-460516 (2019-09-19)
The new approach to the development of planar chromatogram with controlled developing solvent velocity was implemented for gradient reversed-phase chromatography of a test mixture of dyes. The developing solvent components were directly delivered onto the surface of the C18 type
Song Zhang et al.
Scientific reports, 7, 43419-43419 (2017-02-25)
We investigated the mechanism of intramolecular charge transfer and the following radiationless dynamics of the excited states of 1-aminoanthraquinone using steady state and time-resolved absorption spectroscopy combined with quantum chemical calculations. Following photoexcitation with 460 nm, conformational relaxation via twisting of
Vsevolod Katritch et al.
Journal of medicinal chemistry, 53(4), 1799-1809 (2010-01-26)
The recent progress in crystallography of G-protein coupled receptors opens an unprecedented venue for structure-based GPCR drug discovery. To test efficiency of the structure-based approach, we performed molecular docking and virtual ligand screening (VLS) of more than 4 million commercially
查看所有相关文献

全球贸易项目编号

货号GTIN
A39009-100G04061833368206